Cancer Biomarkers: Players, products and prospects (Volume I) : Market Research Report

Cancer Biomarkers: Players, products and prospects (Volume I)

Published by: Espicom Healthcare Intelligence

Published: Aug. 28, 2008 - 138 Pages

EXECUTIVE SUMMARY: What are biomarkers?; Why are they important?; What technologies are involved?; What impact will biomarkers have on R&D?; Who are the major biomarker players and in what research area?; Cancer biomarker companies; Cardiovascular biomarker companies; CNS biomarkers companies; Company Analysis Criteria; Biomarker technology & platforms; Association/clinical studies; Management strategy; Application & potential
CANCER MARKET & REVENUES: Market revenues - global; Market revenues - leading brands; Market revenues - leading players
CANCER EPIDEMIOLOGY, DIAGNOSIS, SCREENING & TREATMENT: Epidemiology; Diagnosis; Screening; Current & future treatment; Future treatment
CANCER BIOMARKERS: Cancer biomarker R&D; Known cancer biomarkers; Probable and possible valid cancer biomarkers
CANCER BIOMARKER OPPORTUNITIES & CHALLENGES: Opportunities; Challenges
BIOMARKER MARKET: Biomarker market revenues - global; Cancer biomarker market revenues - global; Future biomarker market revenues - global; Future cancer biomarker market revenues - global
CANCER BIOMARKER TRENDS: Pharma and specialty pharma deals; Collaborations with service providers; Collaborations with academics and consortia
BIOMARKER ANALYSIS: DNA biomarkers; RNA and microRNA biomarkers; Proteomic biomarkers
KEY BIOMARKER COMPANIES ANALYSED
KEY BIOMARKER EVALUATION CRITERIA
CANCER BIOMARKER- COMPANY ANALYSIS
Abbott Diagnostics: Biomarker novelty & technology platform; Association studies/clinical data; Pivotal Trial; Management strategy; Application & market potential; Biomarker analysis
Affymetrix: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Agendia BV: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
AltheaDx: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
AVEO Pharmaceuticals: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Biomarker novelty & technology platform: Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
BG Medicine: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Beckman Coulter: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
BioCurex: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Biomedical Diagnostics: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Biomerica: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Bruker Daltonics: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Caprion Proteomics: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Clinical Data: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Celera: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Dako Denmark A/S: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
DxS Ltd: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Epigenomics AG: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Epistem Plc: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
GeneNews: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Fujirebio Diagnostics, Inc: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Genomic Health: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Gen-Probe: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Genzyme Genetics: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
InterGenetics: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Ipsogen Therapeutics: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Laboratory Corporation of America: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Matritech: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Monogram Biosciences: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Orion Genomics: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Oxford Genome Biosciences (UK) Ltd: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Power3 Medical Products: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Predictive Biosciences: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Provista Life Sciences: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Quest Diagnostics: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Roche Diagnostics: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
SuperArray Bioscience Corporation: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Third Wave Technologies: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Upstream Biosciences: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Veridex, LLC: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
Vermillion: Biomarker novelty & technology platform; Association studies/clinical data; Management strategy; Application & market potential; Biomarker analysis
CANCER BIOMARKER APPENDIX 1
CANCER BIOMARKER APPENDIX 2
CANCER BIOMARKER APPENDIX 3: Company Analysis Criteria; Biomarker technology & platforms; Association studies; Management strategy; Application & potential
GLOSSARY
ACRONYMS
BIBLIOGRAPHY & ENDNOTES

Abstract

Part of Espicom's new 3-volume report on Cancer, CNS and Cardiovascular Biomarkers, this volume provides a comprehensive analysis of the cancer biomarker sector, along with a critical assessment of the companies involved.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Cancer Biomarkers: Players, products and prospects (Volume I)

Table of Contents

Abstract